Resultats de la cerca - Iyengar, Smriti
- Mostrar 1 - 15 resultats de 15
-
1
-
2
-
3
-
4
-
5
Critical NIH Resources to Advance Therapies for Pain: Preclinical Screening Program and Phase II Human Clinical Trial Network per Iyengar, Smriti, Woller, Sarah A., Hommer, Rebecca, Beierlein, Jennifer, Wright, Clinton B., Tamiz, Amir P., Karp, Barbara I.
Publicat 2020Text -
6
Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial per Wernicke, Joachim F., Raskin, Joel, Rosen, Amy, Pritchett, Yili L., D'Souza, Deborah N., Iyengar, Smriti, Knopp, Kelly, Le, Trong K.
Publicat 2006Text -
7
Imaging Drugs with and without Clinical Analgesic Efficacy per Upadhyay, Jaymin, Anderson, Julie, Schwarz, Adam J, Coimbra, Alexandre, Baumgartner, Richard, Pendse, G, George, Edward, Nutile, Lauren, Wallin, Diana, Bishop, James, Neni, Saujanya, Maier, Gary, Iyengar, Smriti, Evelhoch, Jeffery L, Bleakman, David, Hargreaves, Richard, Becerra, Lino, Borsook, David
Publicat 2011Text -
8
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities per Davis, Karen D., Aghaeepour, Nima, Ahn, Andrew H., Angst, Martin S., Borsook, David, Brenton, Ashley, Burczynski, Michael E., Crean, Christopher, Edwards, Robert, Gaudilliere, Brice, Hergenroeder, Georgene W., Iadarola, Michael J., Iyengar, Smriti, Jiang, Yunyun, Kong, Jiang-Ti, Mackey, Sean, Saab, Carl Y., Sang, Christine N., Scholz, Joachim, Segerdahl, Marta, Tracey, Irene, Veasley, Christin, Wang, Jing, Wager, Tor D., Wasan, Ajay D., Pelleymounter, Mary Ann
Publicat 2020Text -
9
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations per Gewandter, Jennifer S., Dworkin, Robert H., Turk, Dennis C., Farrar, John T., Fillingim, Roger B., Gilron, Ian, Markman, John D., Oaklander, Anne Louise, Polydefkis, Michael J., Raja, Srinivasa N., Robinson, James P., Woolf, Clifford J., Ziegler, Dan, Ashburn, Michael A., Burke, Laurie B., Cowan, Penney, George, Steven Z., Goli, Veeraindar, Graff, Ole X., Iyengar, Smriti, Jay, Gary W., Katz, Joel, Kehlet, Henrik, Kitt, Rachel A., Kopecky, Ernest A., Malamut, Richard, McDermott, Michael P., Palmer, Pamela, Rappaport, Bob A., Rauschkolb, Christine, Steigerwald, Ilona, Tobias, Jeffrey, Walco, Gary A.
Publicat 2015Text -
10
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations per Gewandter, Jennifer S., Dworkin, Robert H., Turk, Dennis C., Farrar, John T., Fillingim, Roger B., Gilron, Ian, Markman, John D., Oaklander, Anne Louise, Polydefkis, Michael J., Raja, Srinivasa N., Robinson, James P., Woolf, Clifford J., Ziegler, Dan, Ashburn, Michael A., Burke, Laurie B., Cowan, Penney, George, Steven Z., Goli, Veeraindar, Graff, Ole X., Iyengar, Smriti, Jay, Gary W., Katz, Joel, Kehlet, Henrik, Kitt, Rachel A., Kopecky, Ernest A., Malamut, Richard, McDermott, Michael P., Palmer, Pamela, Rappaport, Bob A., Rauschkolb, Christine, Steigerwald, Ilona, Tobias, Jeffrey, Walco, Gary A.
Publicat 2021Text -
11
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations per Gewandter, Jennifer S., Dworkin, Robert H., Turk, Dennis C., McDermott, Michael P., Baron, Ralf, Gastonguay, Marc R., Gilron, Ian, Katz, Nathaniel P., Mehta, Cyrus, Raja, Srinivasa N., Senn, Stephen, Taylor, Charles, Cowan, Penney, Desjardins, Paul, Dimitrova, Rozalina, Dionne, Raymond, Farrar, John T., Hewitt, David J., Iyengar, Smriti, Jay, Gary W., Kalso, Eija, Kerns, Robert D., Leff, Richard, Leong, Michael, Petersen, Karin L., Ravina, Bernard M., Rauschkolb, Christine, Rice, Andrew S. C., Rowbotham, Michael C., Sampaio, Cristina, Sindrup, Søren H., Stauffer, Joseph W., Steigerwald, Ilona, Stewart, Jonathan, Tobias, Jeffrey, Treede, Rolf-Detlef, Wallace, Mark, White, Richard E.
Publicat 2014Text -
12
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations per Andrews, Nick A., Latrémolière, Alban, Basbaum, Allan I., Mogil, Jeffrey S., Porreca, Frank, Rice, Andrew S.C., Woolf, Clifford J., Currie, Gillian L., Dworkin, Robert H., Eisenach, James C., Evans, Scott, Gewandter, Jennifer S., Gover, Tony D., Handwerker, Hermann, Huang, Wenlong, Iyengar, Smriti, Jensen, Mark P., Kennedy, Jeffrey D., Lee, Nancy, Levine, Jon, Lidster, Katie, Machin, Ian, McDermott, Michael P., McMahon, Stephen B., Price, Theodore J., Ross, Sarah E., Scherrer, Grégory, Seal, Rebecca P., Sena, Emily S., Silva, Elizabeth, Stone, Laura, Svensson, Camilla I., Turk, Dennis C., Whiteside, Garth
Publicat 2015Text -
13
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations per Smith, Shannon M., Dworkin, Robert H., Turk, Dennis C., McDermott, Michael, Eccleston, Christopher, Farrar, John T., Rowbotham, Michael C., Bhangwagar, Zubin, Burke, Laurie B., Cowan, Penney, Ellenberg, Susan S., Evans, Scott R., Freeman, Roy L., Garrison, Louis P., Iyengar, Smriti, Jadad, Alejandro, Jensen, Mark P., Junor, Roderick, Kamp, Cornelia, Katz, Nathaniel P., Kesslak, J. Patrick, Kopecky, Ernest A., Lissin, Dmitri, Markman, John D., Mease, Philip J., O’Connor, Alec B., Patel, Kushang V., Raja, Srinivasa N., Sampaio, Cristina, Schoenfeld, David, Singh, Jasvinder, Steigerwald, Ilona, Strand, Vibeke, Tive, Leslie A., Tobias, Jeffrey, Wasan, Ajay D., Wilson, Hilary D.
Publicat 2020Text -
14
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT Recommendations per Kleykamp, Bethea A., Dworkin, Robert H., Turk, Dennis C., Bhagwagar, Zubin, Cowan, Penney, Eccleston, Christopher, Ellenberg, Susan S., Evans, Scott R., Farrar, John T., Freeman, Roy L., Garrison, Louis P., Gewandter, Jennifer S., Goli, Veeraindar, Iyengar, Smriti, Jadad, Alejandro R., Jensen, Mark P., Junor, Roderick, Katz, Nathaniel P., Kesslak, J. Patrick, Kopecky, Ernest A., Lissin, Dmitri, Markman, John D., McDermott, Michael P., Mease, Philip J., O’Connor, Alec B., Patel, Kushang V., Raja, Srinivasa N., Rowbotham, Michael C., Sampaio, Cristina, Singh, Jasvinder A., Steigerwald, Ilona, Strand, Vibeke, Tive, Leslie A., Tobias, Jeffrey, Wasan, Ajay D., Wilson, Hilary D.
Publicat 2022Text -
15
Discovery of a Potent, Dual Serotonin and Norepinephrine Reuptake Inhibitor per Dreyfus, Nicolas, Myers, Jason K., Badescu, Valentina O., de Frutos, Oscar, de la Puente, Maria Luz, Ding, Chunjin, Filla, Sandra A., Fynboe, Karsten, Gernert, Douglas L., Heinz, Beverly A., Hemrick-Luecke, Susan K., Johnson, Kirk W., Johnson, Michael P., López, Pilar, Love, Patrick L., Martin, Laura J., Masquelin, Thierry, McCoy, Michael J., Mendiola, Javier, Morrow, Denise, Muhlhauser, Mark, Pascual, Gustavo, Perun, Thomas J., Pfeifer, Lance A., Phebus, Lee A., Richards, Simon J., Rincón, Juan Antonio, Seest, Eric P., Shah, Jikesh, Shaojuan, Jia, Simmons, Rosa Maria A., Stephenson, Gregory A., Tromiczak, Eric G., Thompson, Linda K., Walter, Magnus W., Weber, Wayne W., Zarrinmayeh, Hamideh, Thomas, Craig E., Joshi, Elizabeth, Iyengar, Smriti, Johansson, Anette M.
Publicat 2013Text